TRIM66 and non-small cell lung carcinoma: Specifically, Chen et al. [78] revealed in their research that silencing MMP9 to inhibit the activity of the TGFβ/SMAD pathway significantly reversed the stimulatory effects of TRIM66 overexpression on NSCLC cell migration and invasion.